Article

reviewjournal.comreviewjournal.com on 2024-04-19 17:25

It’s the 1st drug shown to slow Alzheimer’s. Why is it off to a slow start?

The Food and Drug Administration gave Leqembi full approval last summer for patients with early stages of the disease. But sales have lagged.

Related news